Arrhythmia Research Technology, Inc. Regains Compliance with NYSE Amex Exchange Continuing Listing Standards

Arrhythmia Research Technology, Inc., a supplier of medical components, software and services, announced that the NYSE Amex LLC, by its letter dated April 27, 2012, notified the Company that based upon a review of publicly available information, the Company has resolved the continued listing deficiency with respect to Sections 134 and 1101 of the Exchange's Company Guide (the "Company Guide"). The previously reported deficiency related to the delay in the completion of the Company's annual report on Form 10-K for the fiscal year ended December 31, 2011, which was filed with the Securities and Exchange Commission on April 25, 2012. The Company's shares continue to be listed on the Exchange under the symbol "HRT" and the Company remains subject to the Exchange's continuing listing standards. About Arrhythmia Research Technology, Inc. The Company through its wholly-owned subsidiary, Micron Products, Inc., manufactures silver plated and non-silver plated conductive resin sensors and distributes metal snaps used in the manufacture of disposable ECG, EEG, EMS and TENS electrodes. Micron's MIT division provides end-to-end product life cycle management through a comprehensive portfolio of value-added services such as design, engineering, prototyping, manufacturing, machining, assembly and packaging. MIT manufactures custom injection molded products for medical, electronic, industrial and consumer applications, and provides high end mold design, manufacturing and precision machining for various industries. The Company's wholly-owned subsidiary, RMDDxUSA Corp. and its Canadian subsidiary, RMDDx Corporation, is a development stage organization dedicated to the development and commercialization of medical devices and services, medical information technology, medical diagnostics and remote patient monitoring through wireless, Internet and telecommunication technologies. The Company's products also include a customizable proprietary signal-averaging electrocardiography (SAECG) software used in the detection of potentially lethal heart arrhythmias that is reconfigurable for a variety of hardware platforms. For more information please check these websites: https://www.arthrt.com https://www.micronintegrated.com https://www.micronproducts.com https://www.WirelessDx.com